About admin

This author has not yet filled in any details.
So far admin has created 1561 blog entries.

NACDS Addresses DIR Fees, Other “Access Agenda” Priorities in National Drug-Pricing Policy Discussion NACDS responds to request-for-information from HHS Secretary Azar for “Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs”

2018-07-18T16:22:01-04:00Categories: Press Release|Tags: , , , , , , |

NACDS has submitted comments to Health and Human Services Secretary Alex Azar in response to the agency’s request-for-information on drug-pricing public policy issues.

NACDS Applauds Missouri Pro-Pharmacy Legislation to Help Prevent Opioid Abuse Seventy-two percent of Missouri voters support limiting the initial fill of certain opioid prescriptions to seven days

2018-07-11T18:26:33-04:00Categories: Press Release|Tags: , |

NACDS is recognizing the leadership of the Missouri Pharmacy Association, the Missouri Retailers Association, Missouri state legislators, Gov. Mike Parson (R) and bill sponsor Sen. David Sater (R) for the enactment of SB 826 in Missouri.

NACDS RxIMPACT Rallies Senate Support for Action on DIR Fees Urging Senators to sign letter to HHS Secretary is the most recent action of NACDS’ grassroots advocacy program on this pressing issue

2018-07-11T09:02:51-04:00Categories: Press Release|Tags: , , , , , |

NACDS RxIMPACT pharmacy advocates are urging Senators to sign a letter to U.S. Secretary of Health and Human Services Secretary Alex Azar that is being led by Sen. Shelley Moore Capito (R-WV) and Sen. Jon Tester (D-MT).

NACDS, WSPA, NCPA File Key Legal Brief in Washington State Medicaid Lawsuit State reimburses pharmacies significantly lower than any other state in the country, impeding patient access to care; Groups also urge CMS to require Washington State to comply with federal Medicaid reimbursement law

2018-06-27T13:09:54-04:00Categories: Press Release|Tags: , , |

Three pharmacy associations filed an important legal brief this week with the Washington State Court of Appeals, challenging the state’s refusal to reimburse community pharmacies for the costs of providing care and services to disadvantaged Medicaid patients.

Go to Top